Panacea Biotec Limited has informed the Exchange regarding Details of Shares dematerialized during December 2025.
PANACEABIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Panacea Biotec submitted a routine compliance filing to NSE and BSE reporting the dematerialization of shares during December 2025, as required under SEBI Regulation 74(5). Only 1,000 shares belonging to one shareholder, Subrata Mukhopadhyay, were newly converted from physical to electronic form during the month. As of December 31, 2025, the total dematerialized shares stood at 6,11,01,526, with 5,32,20,273 held in NSDL and 78,81,253 in CDSL. The data was certified by the company's Registrar and Transfer Agent, Skyline Financial Services Pvt. Ltd. The change from November 30, 2025 to December 31, 2025 was just 1,000 shares, indicating a very minor activity.
This is a routine procedural disclosure with no material impact on the business, shareholders, or stock price. It simply reflects the ongoing conversion of physical share certificates into electronic (demat) form.